drugset
Drugs / Japanese Encephalitis alive vaccine
last change Mar 2019 re-read 9 days ago

Japanese Encephalitis alive vaccine

also known as LJEV

Vaccine

Developed for
Japanese encephalitis
Investigated by
Centers for Disease Control and Prevention · Centers for Disease Control and Prevention, China · Hubei Provincial Center for Disease Control and Prevention · Zhejiang Provincial Center for Disease Control and Prevention

Trials 1

today NCT02643433 · Ph 4
201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02643433 Aug 2015 → Jun 2016 Japanese encephalitis, measles, rubella Centers for Disease Control and Prevention, China Completed Met primary

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Japanese Encephalitis alive vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02643433 ↗
Known as LJEV “Enrolled infants were randomly assigned (1:1) to receive either measles-rubella vaccine and LJEV simultaneously (measles-rubella plus LJEV group) or measles-rubella vaccine...” PMID 30833160 ↗ Mar 2019
Modality Vaccine “A live attenuated vaccine (LJEV) manufactured in China” NCT02643433 ↗
Route Subcutaneous “be administered by single use syringe subcutaneously in the lower part of the deltoid area of lateral arm” NCT02643433 ↗